CRPC

7 clinical trials · Condition

Record	Firm	Date
A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors (NCT04686682)	Jacobio Pharmaceuticals Co., Ltd.	2021-05-07
A Dose-Finding Study of Birabresib (MK-8628), a Small Molecule Inhibitor of the Bromodomain and Extra-Terminal (BET) Proteins, in Adults With Selected Advanced Solid Tumors (MK-8628-003) (NCT02259114)	Oncoethix GmbH, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)	2014-10-23
A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors and Subsequent Dose Expansion Cohorts (NCT02266745)	Promontory Therapeutics Inc.	2014-07-01
A Study to Evaluate Once-Daily Oral VT-464 in Patients With Castration-Resistant Prostate Cancer (NCT02361086)	Innocrin Pharmaceutical	2014-06-01
A Phase 2 Study to Determine the Safety and Efficacy of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension), Administered to Patients With Metastatic Castration-Resistant Prostate Cancer (NCT01812746)	BIND Therapeutics	2013-04-01
A Study to Evaluate Oral VT-464 in Patients With Castration-Resistant Prostate Cancer (NCT02012920)	Innocrin Pharmaceutical	2011-12-01

Every clearance here is in the API, with alerts when new ones post.